TOKYO -- Japan will begin a clinical trial of a blood plasma treatment for coronavirus patients as early as this month, joining the U.S., Canada and China in experimenting with the century-old treatment.
The treatment involves infusing into patients blood plasma harvested from those who have recovered from COVID-19, the disease caused by the new coronavirus. Such infusions are hoped to contain antibodies that fight against the virus.
